Page last updated: 2024-08-26

2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine and Carcinoma, Transitional Cell

2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with Carcinoma, Transitional Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, CL; Haas, GP; Jones, RF; Morse, P; Shirai, T; Wang, CY1

Other Studies

1 other study(ies) available for 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine and Carcinoma, Transitional Cell

ArticleYear
Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-3, 8-dimethyl-imidazo[4,5-f]quinoxaline and 3, 2'-dimethyl-4-aminobiphenyl in the rat.
    Cancer letters, 2000, Jul-03, Volume: 155, Issue:1

    Topics: Aminobiphenyl Compounds; Animals; Animals, Newborn; Body Weight; Carcinogens; Carcinoma, Transitional Cell; Colonic Neoplasms; Hyperplasia; Imidazoles; Male; Mutagens; Prostatic Neoplasms; Pyridines; Quinoxalines; Rats; Rats, Inbred ACI; Urinary Bladder Neoplasms

2000